Target intelligence / Profile preview

Inflammatory extracellular milieu

Molecular classification
Other
01

Overview

The inflammatory extracellular milieu refers to the complex and dynamic biochemical environment surrounding cells during an inflammatory response. It is composed of a diverse array of signaling molecules, including pro-inflammatory cytokines such as TNF-alpha, IL-1, and IL-6, as well as chemokines, reactive oxygen species (ROS), and proteolytic enzymes like matrix metalloproteinases (Source: Nature Reviews Immunology). This milieu serves to coordinate the immune response, recruit leukocytes to sites of injury, and initiate tissue repair; however, its chronic persistence is a hallmark of autoimmune diseases and the tumor microenvironment (Source: Frontiers in Immunology). In the context of oncology, the inflammatory milieu can promote tumor progression, facilitate angiogenesis, and enable immune evasion (Source: ScienceDirect). While not a single molecular target, many therapeutic interventions aim to alter this environment by neutralizing specific soluble factors or blocking their respective receptors to dampen pathological inflammation (Source: Journal of Clinical Investigation). Consequently, the milieu is a critical focus for drug development in chronic inflammatory and malignant conditions.

Other names
Inflammatory microenvironmentPro-inflammatory milieuInflammatory nicheExtracellular inflammatory environment
02

Mechanism of action

Modulation of the inflammatory environment through the neutralization of specific soluble cytokines, inhibition of leukocyte recruitment, or the reduction of oxidative stress and proteolytic activity.

03

Biological functions

Immune responseSignal transductionCell recruitmentTissue remodelingApoptosisAngiogenesis
04

Disease associations

InflammationCancerAutoimmune diseaseCardiovascular diseaseNeurodegenerative diseaseInfection
05

Safety considerations

Systemic immunosuppressionIncreased risk of opportunistic infectionsImpaired wound healingReactivation of latent tuberculosisPotential for paradoxical inflammatory reactions
06

Interacting drugs

Infliximab

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Erythrocyte sedimentation rate (ESR)Matrix metalloproteinase-9 (MMP-9)

Beyond the preview

Go deeper on Inflammatory extracellular milieu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory extracellular milieu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call